Morteza Mirkarimi in San Diego, California

Home California San Diego

Morteza Mirkarimi has General Practice as his primary medical specialty. Their primary office is: 3863 Clairemont Dr in San Diego, California. They attended Sorry, his university is not listed and graduated in 1968 (around 56 years of experience). They are listed as doing telehealth appointments.

Morteza Mirkarimi Office Phone and Directions

Morteza Mirkarimi
3863 Clairemont Dr
San Diego, California 92117
858-483-5570

Patient Ratings
Please rate your experience with Morteza Mirkarimi below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 858-483-5570

Enter a starting address:

Healthcare Info for Morteza Mirkarimi

Medical School: Sorry, his university is not listed
Graduation Year: 1968
The Primary Medical Specialty for Morteza Mirkarimi is listed as: General Practice
Approximate Years of Experience: 56
PAC (PECOS ID)#: 0941331813
NPI #: 1487757589
NPI Created On: 09/06/2006
NPI Last Updated Listed as: 12/30/2014
Primary Taxonomy Code: 208D00000X
License Number:
A39662
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Routine ekg using at least 12 leads including interpretation and report
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832588893

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: VACCINES

Name of Drug #1: PREVNAR 13

Open Associated Drug #1: 0005-1971-02